drugset / Trial / NCT00167934
Determining Metabolic Effects of Valproate and Antipsychotic Therapy
Completed
164 enrolled
Washington University School of Medicine
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will determine the metabolic processes responsible for high levels of blood glucose, metabolism disorders, and weight gain in people with schizophrenia who have been treated with antipsychotic medications in combination with valproate.
Timeline
- Start
- 2004-12
- Primary completion
- 2008-12
- Completion
- 2008-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valproate | Small molecule | 500 mg | — |
| Subject | Valproate | Small molecule | 3000 mg | — |